Syringe and two needles : One (often purple/red) for drawing up the dose
Note: The effects described below are based on laboratory studies, animal models and, in some cases, clinical human studies
369 developed a gold nanoparticle-mediated drug delivery platform for the co-delivery of doxorubicin and polo-like kinase 1 (Plk1) siRNA, offering an adaptable and straightforward platform for studying drug-siRNA combinations in cancer treatment
Free radicals are unstable molecules that, when in excess, can lead to cellular damage and contribute to chronic diseases and aging
Aqua, Centella Asiatica Leaf Water, Butylene Glycol, Glycerin, Dipropylene Glycol, Niacinamide, Hydroxyethyl Urea, 1, 2-Hexanediol, Hydroxyacetophenone, Propanediol, Glutathione, Allantoin, Panthenol, Styrene/Acrylates Copolymer, Sodium Citrate, Adenosine, Citric Acid, Ethylhexylglycerin, Dipotassium Glycyrrhizate, Sodium Hyaluronate, Squalane, Beta-Glucan, Asiaticoside, Madecassic Acid, Asiatic Acid, Caprylic/Capric Triglyceride, Hippophae Rhamnoides Fruit Extract, Melaleuca Alternifolia Leaf Extract, Hydrolyzed Collagen, Hydrogenated Lecithin, Artemisia Annua Extract, Nelumbium Speciosum Flower Extract, Oryza Sativa Extract, Saccharomyces Ferment, Solanum Melongena Fruit Extract, Glyceryl Stearate, Cholesterol, Xanthan Gum Ingredients may change
Schepers, M